⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2778839 | 0.78 | — | — | |
| SCHEMBL3854074 | 0.76 | — | — | |
| SCHEMBL7204207 | 0.76 | — | — | |
| SCHEMBL9259401 | 0.73 | — | — | |
| SCHEMBL23788219 | 0.73 | GSK3B (0.31) | — | |
| SCHEMBL15279708 | 0.71 | — | — | |
| SCHEMBL2352202 | 0.71 | ALDH1A1 (0.42) | — | |
| SCHEMBL1527656 | 0.71 | TSHR (0.39) | — | |
| SCHEMBL8836807 | 0.71 | GSK3B (0.38) | — | |
| SCHEMBL9256988 | 0.71 | GSK3B (0.38) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025097104-A1 | THIENYL COMPOUNDS FOR THE TREATMENT OF A CENTRAL NERVOUS SYSTEM DISEASE OR DISORDER | PGI DRUG DISCOVERY LLC (US) | 2025-05-08 | — | — | WO | disclosed |
| US-11121327-B2 | Spiro-condensed lactam compounds for organic electroluminescent devices | MERCK PATENT GMBH (DE) | 2021-09-14 | — | — | US | disclosed |
| US-10957864-B2 | Materials for organic light-emitting devices | MERCK PATENT GMBH (DE) | 2021-03-23 | — | — | US | disclosed |
| US-20190326521-A1 | MATERIALS FOR ORGANIC LIGHT-EMITTING DEVICES | MERCK PATENT GMBH (DE) | 2019-10-24 | — | — | US | disclosed |
| EP-3016952-B1 | SPIRO-CONDENSED LACTAM COMPOUNDS FOR ORGANIC ELECTROLUMINESCENT DEVICES | MERCK PATENT GMBH (DE) | 2019-05-15 | — | — | EP | disclosed |
| EP-3110796-B1 | MATERIALS FOR ORGANIC LIGHT-EMITTING DEVICES | MERCK PATENT GMBH (DE) | 2017-12-06 | — | — | EP | disclosed |
| US-20170012219-A1 | MATERIALS FOR ORGANIC LIGHT-EMITTING DEVICES | MERCK PATENT GMBH (DE) | 2017-01-12 | — | — | US | disclosed |
| US-20170012219-A1 | MATERIALS FOR ORGANIC LIGHT-EMITTING DEVICES | MERCK PATENT GMBH (DE) | 2017-01-12 | — | — | US | disclosed |
| US-20160372681-A1 | SPIRO-CONDENSED LACTAM COMPOUNDS FOR ORGANIC ELECTROLUMINESCENT DEVICES | MERCK PATENT GMBH (DE) | 2016-12-22 | — | — | US | disclosed |
| US-20160372681-A1 | SPIRO-CONDENSED LACTAM COMPOUNDS FOR ORGANIC ELECTROLUMINESCENT DEVICES | MERCK PATENT GMBH (DE) | 2016-12-22 | — | — | US | disclosed |
| WO-2015128052-A1 | MATERIALS FOR ORGANIC LIGHT-EMITTING DEVICES | MERCK PATENT GMBH (DE) | 2015-09-03 | — | — | WO | disclosed |
| US-9051315-B2 | Imidazopyridines as a novel scaffold for multi-targeted kinase inhibition | ABBVIE INC. (US) | 2015-06-09 | — | — | US | disclosed |
| WO-2015000542-A1 | SPIRO-CONDENSED LACTAM COMPOUNDS FOR ORGANIC ELECTROLUMINESCENT DEVICES | MERCK PATENT GMBH (DE) | 2015-01-08 | — | — | WO | disclosed |
| CN-102725292-A | Imidazopyridine compounds as novel constructs for multi-target kinase inhibition | ABBOTT LAB | 2012-10-10 | — | — | CN | disclosed |
| EP-2496574-A1 | IMIDAZOPYRIDINES AS A NOVEL SCAFFOLD FOR MULTI-TARGETED KINASE INHIBITION | Abbott Laboratories (US) | 2012-09-12 | — | — | EP | disclosed |
| US-20110124632-A1 | IMIDAZOPYRIDINES AS A NOVEL SCAFFOLD FOR MULTI-TARGETED KINASE INHIBITION | ABBOTT LABORATORIES (US) | 2011-05-26 | — | — | US | disclosed |
| WO-2011053476-A1 | IMIDAZOPYRIDINES AS A NOVEL SCAFFOLD FOR MULTI-TARGETED KINASE INHIBITION | ABBOTT LABORATORIES (US) | 2011-05-05 | — | — | WO | disclosed |